ERA Testing in IVF: When It Is Discussed and Why It Remains Controversial
Key Takeaways
ERA and related endometrial receptivity tests try to personalize embryo transfer timing, but routine use remains controversial because stronger evidence has not shown clear benefit for most IVF patients. These tests are usually discussed only in selected cases, such as repeated implantation failure after a broader clinical review.
ERA Testing in IVF
ERA and related endometrial receptivity tests are designed to answer a very specific question: is the timing of progesterone exposure and embryo transfer aligned with the patient’s personal window of implantation? You can see why the idea became popular. If transfer timing could be personalized, perhaps some difficult IVF cases could be improved. The difficulty is that stronger clinical evidence has still not shown clear routine benefit for most patients.
What ERA tries to measure
ERA is based on endometrial biopsy and gene-expression analysis. The goal is to classify the endometrium as receptive or non-receptive at a specific point in a programmed cycle, then adjust the timing of a later transfer if needed.
In theory, this makes sense. In practice, whether this improves live birth rates for most patients remains uncertain.
Why the test became popular
The test gained traction for a simple reason: repeated failed transfers are exhausting, and transfer timing feels like something clinicians might be able to improve. ERA offered both an explanation and an action plan. For selected clinicians and patients, that was understandably attractive.
It has most often been discussed in the setting of recurrent implantation failure or repeated unsuccessful embryo transfers despite apparently good embryos.
Why routine use is controversial
Several issues keep ERA in the “selected use” category rather than the routine one:
- randomized evidence has not shown clear benefit for the average IVF patient
- implantation failure is often multifactorial, not just a timing problem
- biopsy adds cost, delay, and another treatment step
- transfer timing may already be adequately controlled in well-run frozen cycles
This is why many regulators and professional groups advise caution.
When clinicians may still discuss ERA
ERA is not usually a first-line add-on in standard IVF. It may still come up after broader review in cases such as:
- repeated failed euploid embryo transfers
- recurrent implantation failure after a systematic workup
- unusual concerns about progesterone timing or prior cycle synchronization
Even in these settings, it is better framed as a selective strategy than as a proven universal solution.
What should be reviewed before ordering it
Before moving to receptivity testing, clinicians usually need to review more basic and more common explanations for failed transfer, including:
- embryo quality or ploidy status
- uterine cavity pathology
- transfer technique
- hydrosalpinx
- endometritis or other cavity factors when clinically indicated
- progesterone timing and route in the actual treatment protocol
If these more common questions have not been addressed first, receptivity testing becomes much harder to justify.
Related Reading
- Embryo Grades Like 4AA, 3BB, and 5BC: What They Actually Mean
- IUI with a Partner’s Sperm: Who It Helps and What Success Rates Mean
- Can Preimplantation Genetic Testing Be Used for Sex Selection?
FAQ
Does ERA improve IVF success for everyone?
No. Current evidence does not support routine use for all IVF patients.
Is ERA mainly used in recurrent implantation failure?
Yes. That is the clinical context in which it is most often discussed, although even there the evidence remains debated.
Does a non-receptive result prove why previous transfers failed?
No. It may point to one possible factor, but failed implantation is often multifactorial and rarely explained by a single test alone.
Should ERA be done before a first embryo transfer?
Usually no. It is generally considered a later-line discussion rather than a routine first-cycle step.
Sources
- Human Fertilisation and Embryology Authority. Endometrial receptivity testing
- ESHRE Working Group on Recurrent Implantation Failure. ESHRE good practice recommendations on recurrent implantation failure
- Doyle JO et al. Effect of Timing by Endometrial Receptivity Testing vs Standard Timing of Frozen Embryo Transfer on Live Birth in Patients Undergoing In Vitro Fertilization
The content has been created by Dr. Senai Aksoy and medically approved.